copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Elucid | Visualize Lesion-level Plaque Composition Developed in partnership with world-renowned cardiovascular pathologists, ground truth histology serves as the basis for training Elucid’s powerful algorithm to objectively quantify vessel structure and plaque composition
Elucid Receives U. S. 510 (k) Clearance of PlaqueIQ™ Image Analysis . . . Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
News - Elucid BOSTON – March 3, 2025 – Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has added several senior members to its clinical and commercial teams
Elucid Raises $80 Million in Series C Round Led by Elevage Medical . . . Elucid is a Boston-based medical technology company dedicated to bringing precision patient care, as currently practiced in oncology, to cardiology Its AI-powered imaging analysis software is designed to understand the root cause of cardiovascular disease deeply
Elucid Announces Favorable Medicare Coverage of AI Coronary Plaque . . . Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ . . . Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
Elucid Names Kelly Huang as CEO Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to help physicians better understand the root cause of cardiovascular disease
Elucid Presents Data Demonstrating Its AI Software Can Uniquely . . . Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease
Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH . . . Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease